Impact of Adjunctive Cilostazol on Microvascular Resistance in Non-ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventio
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0000044
- Lead Sponsor
- Koera University Guro Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1) Age >= 18years
2) Patients with Non-ST elevation myocardial infarction who underwent percutaneous coronary intervention within 72hours
3) Single coronary lesion
4) Patients who can medicated with dual antiplatelet drugs, at least 6 months after PCI
Exclusion Criteria
1) ST-elevation myocardial infarction, Unstable angina, Stable angina
2) Cardiogenic shock
3) Renal insufficiency (creatinine >2.0 mg/dl)
4) Life expectancy < 1 year
5) Severe liver dysfunction
6) Pregnancy or immune deficiency
7) Bleeding tendency or coagulopathy
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of Index of microvascular resistance
- Secondary Outcome Measures
Name Time Method All major adverse cardiovascular events ;All major adverse cardiovascular events